Covered recipient · General Payments record
ALISHA R MILLER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2025
$865.08
- Reported across 33 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $313.43 | 19 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $168.88 | 12 |
| Novo Nordisk AS | $80.11 | 3 |
| Lilly USA, LLC | $37.24 | 2 |
| Stryker Corporation | $16.10 | 1 |
| Phathom Pharmaceuticals, Inc. | $11.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.08 | 01/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203084255 | CMS |
| ABBVIE INC. | $26.17 | 02/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203084257 | CMS |
| ABBVIE INC. | $15.51 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203084259 | CMS |
| ABBVIE INC. | $17.21 | 04/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203084261 | CMS |
| ABBVIE INC. | $12.44 | 06/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203084263 | CMS |
| ABBVIE INC. | $11.10 | 06/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203084265 | CMS |
| ABBVIE INC. | $5.96 | 08/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203084267 | CMS |
| ABBVIE INC. | $8.17 | 08/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203084269 | CMS |
| ABBVIE INC. | $21.16 | 10/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203084271 | CMS |
| ABBVIE INC. | $5.99 | 10/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203084273 | CMS |
| ABBVIE INC. | $6.12 | 10/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203084275 | CMS |
| ABBVIE INC. | $22.97 | 12/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203084277 | CMS |
| Lilly USA, LLC | $19.47 | 01/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186502729 | CMS |
| Lilly USA, LLC | $17.77 | 04/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186502731 | CMS |
| Novo Nordisk Inc | $21.50 | 08/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188499775 | CMS |
| Novo Nordisk Inc | $23.68 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188763859 | CMS |
| Novo Nordisk Inc | $34.93 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188166949 | CMS |
| Phathom Pharmaceuticals, Inc. | $11.10 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219318957 | CMS |
| Stryker Corporation | $16.10 | 04/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249037775 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.